Sumitomo Riko, in collaboration with Ginreilab, has completed a Microphysiological Systems (MPS) prototype, which can be used to confirm the efficacy and evaluate the safety of pharmaceuticals and other products, the company revealed at the 22nd Annual Meeting of the Japanese Society for Regenerative Medicine. In recent years, the global trend has been to verify the efficacy and safety of…
Please subscribe to read the full story.Subscribe
Already a member? Log in here
